Investment Pitches

Pitch Summary:
Nvidia Corporation is a leading supplier of graphics processing units (GPUs) for a variety of end markets, such as gaming, PCs, data centers, virtual reality, and high-performance computing. The company is leading in most secular growth categories in computing, and especially AI and super-computing parallel processing techniques for solving complex computational problems. In our view, Nvidia’s computational power is a critical enabler of AI and therefore essential to AI adoption. Shares rose during the quarter after the company reported better-than-expected first-quarter operating results, where total revenues grew 69% year-over-year (y/y). Strong revenue growth was fueled by a 73% y/y increase in data center sales; that segment now contributes 89% of Nvidia’s revenue as AI workloads shift to compute-intensive inference and large “AI factory” build outs. Further, Blackwell (GB-200) chips currently generate 70% of data center revenue, nearly completing the transition from Hopper, its previous GPU architecture. In our view, Nvidia is extending its lead with Blackwell Ultra (GB-300), now in trials, which retains the same architecture but offers 50% more high-bandwidth memory and up to 50% faster inference performance than the GB-200, according to management.

BSD Analysis:
NVIDIA is the gravitational center of the AI universe — everything eLondon Stock Exchange orbits around it. Demand is overwhelming supply, margins are stellar, and the company’s software ecosystem ensures its hardware advantage compounds over time. Blackwell isn’t just another chip — it’s the next governor of global compute. NVIDIA is sucking all the oxygen out of the AI budget, and competitors can’t keep up. The stock looks expensive because greatness is expensive. NVIDIA is the toll operator of the AI revolution.

Pitch Summary:
Enterprise Products Partners is a leading midstream MLP with a vertically integrated system of pipelines, storage, processing, and export terminals, anchored by irreplaceable complexes at Mont Belvieu and the Houston Ship Channel. Its asset base, heavily exposed to NGLs, provides a competitive advantage and positions it to benefit from U.S. petrochemical growth and low-cost Permian Basin supply. EPD boasts strong governance with 32% insider ownership (primarily the Duncan family), no IDRs, and a long history of owner-oriented capital allocation. At ~$31, units yield 7% with 1.7× DCF coverage, allowing reinvestment into high-return projects (~12% pre-tax ROIC). Management has compounded distributions for 26 years while maintaining a conservative balance sheet (3.1× debt/EBITDA, 17.7-year average tenor, 4.7% coupon). A robust $6B growth capex pipeline (new NGL pipeline, processing plants, fractionator, export terminal) is set to add ~$700M of EBITDA by 2025, providing visible growth. Absent multiple expansion, the author expects 10.5%+ annual total returns from the 7% yield plus 3–4% annual distribution growth. This combination of asset quality, balance sheet strength, and disciplined reinvestment makes EPD a reliable long-term hold in midstream energy.

BSD Analysis:
BSD view: EPD represents a high-quality, defensive way to gain exposure to U.S. midstream energy with attractive, tax-advantaged income and growth. The key strengths are vertical integration, governance, and self-funding growth. Risks are relatively modest—cyclical commodity exposure is muted given fee-based contracts, but volume growth still depends on U.S. hydrocarbon demand and export competitiveness. Longer-term, the main bear case is energy transition risk, but EPD’s diversified NGL/petrochemicals positioning should mitigate. Overall, a solid core income compounder.

Pitch Summary:
ATG is a leading digital auction platform that connects 4,000+ auctioneers and millions of bidders across 170 countries. It operates eight marketplaces and a white-label solution across Industrial & Commercial (I&C) and Arts & Antiques (A&A). Revenue is monetized via SaaS fees, commissions, and value-added services (VAS) such as payments, escrow, and shipping, which have grown at 45% CAGR since FY20. Growth levers include rising digital penetration of auctions, further VAS adoption, higher GMV monetization, cross-listing, international expansion, and M&A. Despite strong fundamentals, shares have sold off ~70% from their post-IPO peak due to macro weakness, slowing I&C growth, and concerns about GMV/THV conversion rates. However, recent data show stabilization, with both A&A and I&C THV returning to growth in late 2024 and early 2025, while JPM tracking data suggests further improvement in Q3. ATG trades at just 14x EV/EBITDA, near its post-IPO lows and at a discount to peers like Autotrader and Ritchie Brothers. With an asset-light model, expanding EBITDA margins (targeting ~50%), and ongoing buybacks (~5% per year), mid-to-high teens EPS growth is expected. The author projects a 35%+ IRR over three years as growth reaccelerates and valuation re-rates.

BSD Analysis:
BSD view: ATG combines vertical marketplace dynamics with SaaS-like economics, offering structural growth from digital adoption and high-margin VAS. Near-term cyclical pressures in I&C auctions weighed on sentiment, but share loss fears look overstated as ATG continues to gain market share. Key risks include prolonged macro weakness, slower monetization of white-label GMV, or execution missteps internationally. Overall, ATG looks like a classic compounder temporarily mispriced by cyclical headwinds.

Pitch Summary:
The pitch argues the market is overestimating the unit economics of Toast’s expansion into Enterprise, International, and adjacent verticals, especially for POS/software-only deployments that don’t bundle payments. As enterprise rollouts (e.g., Applebee’s) scale in 2H, the author expects lower gross profit per location versus SMBs, pressuring consensus FY26+. Key headwinds: enterprises demand interchange+ pricing (vs. SMB “flat” MDR), lower attach on high-margin add-ons (e.g., Toast Capital), and limited uptake of Toast’s ancillary software in favor of existing enterprise systems. To offset, Toast would need sizable price increases on core SMBs despite intensifying competition (Square, Fiserv/Clover, Shift4/Skytab, Lightspeed, possible DoorDash POS). Sales & marketing efficiency is already slipping as TAM penetration rises, while further opex cuts risk service quality and product velocity. The author also flags reporting choices (ARR including payments, “net revenue” akin to GP, EBITDA as % “adjusted recurring GP”) that can mask pressure in core economics. With shares at ~45× forward EBITDA (~35–40× FY26), any miss or mix-shift toward lower-margin enterprise/international could drive a sharp de-rating toward integrated-payments peers. Sensitivity work shows FY26 adj. EBITDA materially below consensus if expansion GPPL underwhelms. Overall: great product, but risk that growth comes at worse unit economics than the market embeds.

BSD Analysis:
BSD view: Credible short setup if enterprise/international mix dilutes GP per location and consensus still extrapolates SMB-like economics. The thesis leans on realistic buyer behavior (interchange+, lower add-on attach) and rising competition. Main risk to the short is Toast sustaining SMB pricing power and proving higher enterprise software monetization and payments attach than history suggests; another risk is continued multiple support from “vertical software” narrative despite payments-centric economics.

Pitch Summary:
Opaque vendor drives 250% growth, fraud allegations and lawsuit, ~$299m uncollected arbitration receivables could be void.

BSD Analysis:
Blue Orca accuses Nutex of fabricating growth through opaque vendor relationships, claiming a related-party vendor accounted for exaggerated revenue growth. The report stresses governance failures, lack of transparency in contracts, and potential fraud. With an aggressive roll-up model and minimal disclosure, Nutex’s fundamentals appear weak relative to its valuation. Investors face asymmetric downside if auditors or regulators question the legitimacy of its reported results.

Pitch Summary:
Aggressive governance, board links to prior restatements/fraud cases, slowing core growth, EBITDA and free cash flow overstated, 20–50% downside.

BSD Analysis:
Spruce Point highlights governance issues at Limbach, pointing to board members’ ties to prior restructurings and aggressive accounting around project recognition. While revenue visibility is supported by backlog, margins are slim and working-capital needs create cash flow volatility. Spruce argues that valuation does not reflect cyclicality of nonresidential construction or risk of write-downs from cost overruns. Downside exists if execution falters in a tighter credit and construction demand environment.

Pitch Summary:
Inogen, Inc. has experienced significant volatility, with its stock price declining by approximately 35% over the past two years. The company's recent acquisition of Physio-Assist SAS, a move into a new treatment domain, raises concerns about strategic focus and financial prudence. Despite receiving FDA clearance for a new device, the acquisition is not expected to be earnings-accretive until 2027. Management changes and a strategic partnership with a Chinese firm add further uncertainty. While the company's balance sheet remains strong, providing some downside protection, the lack of clarity on earnings recovery leads to a Hold rating.

BSD Analysis:
Inogen's financial position is bolstered by a substantial cash reserve, representing about 72% of its market capitalization as of Q1 2025. However, the company's strategic decisions, such as the acquisition of Physio-Assist and the partnership with Yuwell, introduce risks that could impact future profitability. The acquisition, costing up to $45 million, diverts resources from Inogen's core business and may not yield returns until 2027. The partnership with Yuwell, while potentially opening new markets, comes amid geopolitical tensions that could affect trade. Inogen's valuation, with a reduced EV/EBIT multiple of 15x, reflects these uncertainties. Despite a positive adjusted EBITDA in Q1 2025, the company's ability to sustain earnings growth remains in question. The new leadership team appears more conservative, which may stabilize operations, but the potential for large, non-value-accretive acquisitions remains a key risk.

Pitch Summary:
Dollarama presents a compelling investment opportunity due to its robust business model and strategic expansion plans. The company has consistently delivered strong financial performance, with impressive growth in revenues, operating income, and earnings per share over the past decade. Its recent expansion into Australia and Mexico offers significant potential for long-term growth, while its established presence in Canada and Latin America provides a solid foundation. Despite a slightly overvalued stock price, the company's ability to maintain high returns on invested capital and improve operating margins supports a bullish outlook.

BSD Analysis:
Dollarama's strategic expansion into international markets, particularly Australia and Mexico, is poised to drive future growth. The acquisition of The Reject Shop in Australia presents an opportunity to enhance profitability through improved management practices. In Canada, Dollarama's strong brand reputation and extensive distribution network solidify its market leadership. The company's financial health is underscored by a low debt-to-free cash flow ratio and efficient inventory management, contributing to high returns on invested capital. While the stock is currently trading at a premium, the long-term growth prospects and potential for margin expansion in new markets justify a bullish stance. Investors should monitor the company's ability to execute its international expansion strategy and manage competitive pressures in new regions.

Pitch Summary:
Nkarta, Inc. is positioned to potentially revolutionize the treatment of autoimmune diseases with its innovative CAR-NK cell therapies. Despite the inherent risks and uncertainties associated with pioneering a new therapeutic approach, the company's solid financial position provides a substantial runway to advance its clinical trials. The upcoming data presentations in 2025 could serve as a significant catalyst for the stock, especially if they demonstrate efficacy in autoimmune conditions.

BSD Analysis:
Nkarta's strategic pivot from oncology to autoimmune diseases represents a bold move to capture a largely untapped market. The company's financial health, with over $52 million in cash and substantial short-term investments, ensures it can sustain operations well into the future without immediate capital raises. However, the viability of engineered NK cell therapy in autoimmune diseases remains unproven, posing a significant risk. The company's ongoing trials, Ntrust-1 and Ntrust-2, are crucial in determining the potential success of its therapies. If successful, Nkarta could establish a new paradigm in autoimmune treatment, but investors should remain cautious given the experimental nature of the technology and the potential for adverse events associated with lymphodepleting chemotherapy. The market's current support suggests a cautious optimism, but the real test will come with the clinical data readouts expected in the latter half of 2025.

Pitch Summary:
Steel Dynamics is positioned to benefit from the increased tariffs on steel and aluminum, which provide a competitive edge over foreign imports. The company's expansion into aluminum production, despite initial costs, is expected to drive future growth. With a solid balance sheet and strategic buybacks, STLD is poised for long-term value creation.

BSD Analysis:
Steel Dynamics has strategically leveraged the current tariff environment to enhance its competitive position. The company's recent financial performance was impacted by one-time costs related to its new facilities, but these are expected to dissipate, allowing for improved profitability. The expansion into aluminum, particularly with the Mississippi plant, positions STLD to capture growth in less-cyclical markets. Despite a challenging Q2, the company's strong cash flow generation and prudent capital management, including debt repayment and share buybacks, underscore its resilience. With a forward P/E of approximately 11x based on 2026 earnings, STLD offers an attractive valuation, especially as capital expenditures are set to decline post-2027, enhancing free cash flow and shareholder returns.

Pitch Summary:
Nebius is positioned as a promising player in the AI cloud market, offering a full-package AI cloud platform that caters specifically to small and midsized companies. The company differentiates itself from larger competitors like AWS and Azure by providing flexible, on-demand GPU pricing without long-term commitments. With strategic partnerships, notably with NVIDIA, and ambitious revenue growth forecasts, Nebius is poised for significant expansion. Despite current financial losses, the company's unique market position and growth potential make it an attractive investment opportunity.

BSD Analysis:
Nebius's impressive revenue growth, with a nearly 700% increase in ARR, underscores its rapid market penetration. The company's strategic focus on small to midsized enterprises allows it to capture a niche segment underserved by larger cloud providers. Its partnership with NVIDIA enhances its technological capabilities, particularly with next-generation chip support. However, the company faces challenges, including substantial cash burn and competition from hyperscalers like AWS. The risk of future dilution due to capital needs is a concern, but management's commitment to minimizing share dilution is reassuring. If Nebius achieves its revenue targets, its valuation could see substantial upside, supported by a projected $4.6 billion revenue in the midterm and potential EBITDA margins exceeding 30% in the long term. Investors should weigh these growth prospects against the inherent risks of an unprofitable, rapidly scaling tech company.

Pitch Summary:
Robert Half Inc. is currently facing significant challenges, as evidenced by its recent earnings miss and declining financial metrics. Despite a historically strong dividend growth, the company's revenue and profit margins have been under pressure, leading to a substantial drop in stock price. While the stock is trading at a discount to its estimated fair value, the ongoing financial struggles and a disappointing Q1 2025 earnings report suggest caution. Investors should be wary of the potential for continued volatility and financial underperformance.

BSD Analysis:
Robert Half's recent financial performance highlights several areas of concern. The company's revenue per share has been inconsistent, with notable declines in the past two fiscal years. Additionally, the gross profit margin has decreased, mirroring the revenue trends. The return on invested capital, which peaked at nearly 62% in FY22, has also seen a downturn. Despite a robust dividend yield of 5.64% and a history of dividend growth, the payout ratio has surged above 85%, raising questions about sustainability. The stock's valuation, based on a custom free cash flow analysis, suggests it is trading at a discount, with a fair value estimate of $48 compared to the current price of around $42. However, the company's ability to rebound from its weak Q1 2025 earnings remains uncertain, and potential investors should consider the risks of further financial deterioration and market volatility. For those holding the stock, the attractive dividend yield may offer some compensation for the risks involved.

Pitch Summary:
Cinemark is poised for a strong recovery as the cinema industry rebounds from COVID-19 and Hollywood strikes. With film production ramping up, Cinemark stands to benefit from increased attendance and high-margin concessions. The company's clean balance sheet and potential for capital returns make it an attractive investment.

BSD Analysis:
Cinemark's recovery is underpinned by a robust pipeline of film releases, with expectations for wide releases to surpass pre-COVID levels by 2025 and 2026. The company's ability to maintain average revenue per wide release suggests resilient consumer demand, even as ticket prices rise. Cinemark's strategic focus on suburban markets, where competition from OTT platforms is less intense, further supports its growth prospects. The anticipated payoff of $460 million in convertible debt by August 2025 will strengthen its capital structure, reducing leverage and enabling potential shareholder returns. Valuation-wise, a return to pre-COVID trading multiples could see the stock price appreciate significantly, aligning with the projected target price of $45. However, risks remain, particularly if film supply falters or inflationary pressures impact margins.

Pitch Summary:
G-III Apparel Group, Ltd. is currently undervalued, trading at a P/E ratio of less than 6.0, which does not reflect its potential for growth through brand synergies and international expansion. The company's diverse brand portfolio and strategic partnerships position it well to capitalize on a rebound in global discretionary spending. An intrinsic valuation suggests a 100% upside, making it an attractive buy.

BSD Analysis:
G-III's financial performance has been robust, with net sales and net income showing year-over-year growth despite global economic challenges. The company's strategic partnerships, such as those with AWWG and ALDO, are expected to drive international expansion and digital growth, mitigating risks associated with declining department store sales. The DCF valuation model, using a conservative growth assumption and a discount rate of 10.8%, indicates significant undervaluation with an intrinsic value of $46.15 per share. While tariff uncertainties pose short-term risks, G-III's management has strategies in place to mitigate these impacts, including sourcing diversification and operational efficiencies. The company's strong brand portfolio and expansion strategies provide a solid foundation for long-term growth, making it a compelling investment opportunity.

Pitch Summary:
MNTN Inc. has established a strong foothold in the connected TV advertising space, particularly among small and medium-sized businesses. The company's unique access to premium ad inventory through direct deals with major streaming platforms provides a competitive edge and supports expanding margins. However, despite its impressive growth and strategic advantages, the current valuation appears to fully reflect these positives, leaving limited upside potential.

BSD Analysis:
MNTN's strategic partnerships with major streamers like NBC and Fox allow it to secure high-quality, non-skippable ad inventory at favorable rates, which is crucial for maintaining its competitive edge. The company's 'Verified Visits' technology enhances its value proposition by linking ad views to conversion events, thereby increasing customer retention and spending. Despite a robust net revenue retention rate of 111% in Q1 2025, the stock's valuation seems stretched, trading at a forward EBITDA multiple comparable to The Trade Desk, a larger and more established competitor. While MNTN's growth rate outpaces that of The Trade Desk, its smaller scale and market position may warrant a valuation discount. The company's focus on the untapped SMB market offers significant growth potential, but execution risks remain, particularly if competition intensifies or if its reliance on CTV inventory becomes a vulnerability. Overall, while MNTN's business model is compelling, the stock's current price may not offer an attractive entry point without further evidence of sustained growth or a market re-rating.

Pitch Summary:
Centene Corporation (CNC) is currently undervalued, trading at approximately half its book value and at a significant discount compared to its peers. Despite a temporary setback in earnings guidance due to higher-than-expected medical utilization, the company is poised for recovery. CNC plans to adjust premiums to offset increased costs, a standard practice in the insurance industry. The market's reaction to the guidance cut has been overly negative, presenting a unique buying opportunity for value investors.

BSD Analysis:
Centene's current valuation metrics are compelling, with the stock trading at 9.1x forward earnings and expected to drop to 4-6x as earnings normalize. This is significantly lower than peers like UnitedHealth and Elevance, which trade at higher multiples. The company's ability to adjust premiums in response to rising medical costs ensures long-term margin stability. Regulatory risks, such as potential Medicaid cuts, are mitigated by the company's historical resilience and adaptability to policy changes. The market's mispricing appears to stem from a lack of understanding of the insurance business model, where premium adjustments naturally follow cost increases. If Centene's earnings stabilize at $5-6 per share, a re-rating to historical multiples could see the stock price more than double, offering substantial upside potential. The current market inefficiency presents a rare opportunity to acquire a leading insurer at a significant discount to intrinsic value.

Pitch Summary:
Trigano SA presents a compelling investment opportunity due to its dominant market position in the European RV industry, strong historical growth, and attractive valuation. The company has achieved significant market share gains through organic growth and strategic acquisitions, resulting in robust financial performance with high returns on equity. Its capital-light business model and strong balance sheet further enhance its competitive edge, allowing for continued market share expansion and potential for accretive acquisitions.

BSD Analysis:
Trigano's strategic positioning as a low-cost producer in the RV industry, akin to Ryanair in air travel, provides it with a durable competitive advantage. The company's ability to leverage purchasing power and maintain cost discipline has enabled it to consistently gain market share while maintaining healthy operating margins. Trigano's net cash position and history of acquiring assets at favorable terms during industry downturns further bolster its resilience and growth prospects. The demographic trends in Europe, with an aging population inclined towards RV travel, provide a favorable backdrop for sustained industry growth. However, potential risks include the founder's advanced age and the lack of a clear succession plan, as well as regulatory challenges related to the transition from diesel to electric powertrains. Despite these risks, Trigano's valuation at a double-digit free cash flow yield and its strong competitive position offer a significant margin of safety and attractive long-term return potential.

Pitch Summary:
Rambus Inc has successfully transformed into a capital-light, fabless semiconductor company with a strong focus on high-performance memory and interface technologies. Despite its strategic repositioning and improved financial metrics, the current market price of $68 per share exceeds the intrinsic value of $59 per share, leaving no margin of safety for value investors. The company's extensive patent portfolio and high switching costs provide a competitive edge, but the optimistic assumptions required to justify the current valuation suggest limited upside potential.

BSD Analysis:
Rambus has demonstrated a significant turnaround, with revenue growing at a 7.3% CAGR from 2015 to 2024, driven by both organic growth and acquisitions. Its fabless model and focus on IP licensing have resulted in high operating leverage, allowing more revenue to translate into profits. However, the company's valuation appears stretched, with a projected 66% ROIC and 40% EBIT margin in the terminal year, which would place it above its peers. While Rambus is financially sound, with $514 million in cash and minimal debt, the lack of a margin of safety at current prices suggests that much of its strategic progress is already reflected in the stock price. Investors should be cautious of the optimistic growth assumptions and potential challenges in maintaining margins as the company scales.

Pitch Summary:
JEPI is recommended as a strategic allocation for investors looking to hedge against potential market corrections in the S&P 500. By utilizing a covered call strategy, JEPI provides income generation while maintaining exposure to large-cap U.S. stocks. This approach offers a balanced risk profile, capturing some upside potential while mitigating downside risks through option premiums.

BSD Analysis:
JEPI's portfolio is diversified across various sectors, with a lower concentration in technology compared to the S&P 500, which reduces exposure to high-beta stocks that have driven recent market gains. The fund's dividend yield of 8.3% provides a steady income stream, appealing to investors seeking returns in a potentially volatile market environment. Historically, JEPI has demonstrated lower volatility and smaller drawdowns compared to SPY, particularly during market downturns. This makes it an attractive option for risk-averse investors. The current market conditions, characterized by elevated valuations and concentrated tech exposure, suggest a prudent shift from SPY to JEPI could enhance portfolio resilience. However, investors should be aware that JEPI's upside is capped due to its covered call strategy, which may limit gains in a strong bull market.

Pitch Summary:
Ducommun's stock surged by 42.39% in Q2 2025, driven by robust order flows and production from major aerospace players like Boeing and Airbus. The company's strategic focus on improving margins and its alignment with increasing defense spending by European NATO countries underpin its growth potential. Ducommun's Vision 2027 targets and a strong revenue outlook further support the investment thesis.

BSD Analysis:
Ducommun's performance is bolstered by a favorable industry backdrop, with increased defense budgets in Europe and strong demand from commercial aerospace giants. The company's margin improvement initiatives are crucial, as they align with its Vision 2027 goals, potentially enhancing profitability. The aerospace and defense sector's resilience, coupled with Ducommun's strategic positioning, suggests sustained growth. The company's ability to capitalize on production efficiencies and its commitment to expanding its market presence are key drivers. Given the sector's cyclical nature, Ducommun's focus on operational excellence and strategic partnerships will be vital in navigating potential market fluctuations.